Artiva Biotherapeutics（ARTV.US）股东结构 - 机构持仓、大股东与内部人士｜长桥证券

股东类型

机构投资者40.23%
风投/私募37.52%
上市公司12.17%
对冲基金5.28%
个人与内部人士4.79%

主要股东

主要股东最新
股东
RA Capital Management, L.P.	37.82%	1,848.93 万	1.02%	+53.37 万	2026/07/31
GC Cell Corporation	12.27%	599.97 万	6.21%	+143.23 万	2026/05/11
Viking Global Investors LP	5.33%	260.42 万	--	+260.42 万	2026/06/30
Blackstone Alternative Investment Advisors LLC	4.92%	240.34 万	4.92%	+240.34 万	2026/06/30
5AM Venture Management, LLC	4.81%	235.33 万	4.71%	+0	2026/06/30
VR Management, LLC	4.18%	204.36 万	2.33%	+43.40 万	2026/06/30
Franklin Templeton Inc.	4.09%	199.72 万	1.98%	+147.69 万	2026/06/30
Caligan Partners, LP	3.55%	173.61 万	--	+173.61 万	2026/06/30
Fred AslanCEO, Principal Financial & Accounting Officer and Director	3.28%	160.48 万	0.14%	+6.97 万	2026/09/15
Vanguard Capital Management, LLC	2.31%	113.02 万	1.34%	+88.97 万	2026/06/30
Samsara BioCapital LLC	1.95%	95.49 万	--	+95.49 万	2026/06/30
CHI Advisors LLC	1.79%	87.45 万	--	+87.45 万	2026/06/30
Propel Bio Management, LLC	1.42%	69.64 万	0.93%	+57.33 万	2026/06/30
BlackRock, Inc.	1.42%	69.47 万	0.56%	+48.13 万	2026/06/30
Citadel Advisors LLC	1.25%	60.94 万	1.18%	+59.35 万	2026/06/30
Silverarc Capital Management, LLC	1.07%	52.50 万	--	+52.50 万	2026/06/30
Geode Capital Management, LLC	0.72%	35.38 万	0.31%	+25.22 万	2026/06/30
Christopher HoranChief Technical Operations Officer	0.66%	32.31 万	0.06%	+2.96 万	2026/09/09
Boothbay Fund Management, LLC	0.64%	31.44 万	--	+31.44 万	2026/06/30
Nantahala Capital Management, LLC	0.61%	30.00 万	0.34%	+23.17 万	2026/06/30